• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

刻痕片剂——药物剂量计算中的误差来源?

The scored tablet--a source of error in drug dosing?

作者信息

Stimpel M, Vetter H, Küffer B, Groth H, Greminger P, Vetter W

出版信息

J Hypertens Suppl. 1985 Apr;3(1):S97-9.

PMID:3870476
Abstract

To determine the weight deviation of scored tablets after breaking we took 100 tablets of each of 34 brands of commercially available antihypertensive drugs and broke them into two, using the scored line. We graded the weights of the tablet halves according to their deviation from the expected weight (1 = less than or equal to +/- 5%, 11 = +/- 6-10%, 111 = greater than or equal to +/- 10%). The brands were ranked by the proportion of tablet halves (n = 200) in each category. Only seven brands divided very accurately and 11 brands divided reasonably accurately. Despite the scored line the remainder were either moderately (n = 10) or absolutely (n = 6) unsuitable for breaking, by hand or otherwise. A high proportion of these tablet halves showed weight deviations of 6-10% or more than 10% when compared to the expected weight. These findings show that a great number of antihypertensive drugs do not break evenly despite a scored line. This leads to inaccuracy of dosage.

摘要

为了确定刻痕片剂掰断后的重量偏差,我们选取了34种市售抗高血压药物品牌中的每种100片,并利用刻痕线将它们掰成两半。我们根据片剂半片的重量与预期重量的偏差对其进行分级(1级 = 小于或等于±5%,2级 = ±6 - 10%,3级 = 大于或等于±10%)。各品牌按照每个类别中片剂半片(n = 200)的比例进行排名。只有7个品牌分割得非常准确,11个品牌分割得较为准确。尽管有刻痕线,但其余品牌要么中度(n = 10)要么完全(n = 6)不适合手工或其他方式掰断。与预期重量相比,这些片剂半片中很大一部分显示出6 - 10%或超过10%的重量偏差。这些发现表明,尽管有刻痕线,大量抗高血压药物仍不能均匀掰断。这会导致剂量不准确。

相似文献

1
The scored tablet--a source of error in drug dosing?刻痕片剂——药物剂量计算中的误差来源?
J Hypertens Suppl. 1985 Apr;3(1):S97-9.
2
[Divisible tablets--source of error in therapeutic drug dosages].[可分割片剂——治疗药物剂量误差的来源]
Schweiz Rundsch Med Prax. 1985 Jan 29;74(5):84-6.
3
Development of an in vivo test procedure for the ease of breaking of scored tablets.开发一种用于评估刻痕片剂易掰断性的体内测试程序。
Pharmeur Sci Notes. 2005 Aug;2005(1):27-30.
4
Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications.6种常见可分割药物半片的药物含量及重量均匀度分析
J Manag Care Pharm. 2009 Apr;15(3):253-61. doi: 10.18553/jmcp.2009.15.3.253.
5
Relationship between Age and the Ability to Break Scored Tablets.年龄与掰开刻痕片剂能力之间的关系
Front Pharmacol. 2016 Jul 26;7:222. doi: 10.3389/fphar.2016.00222. eCollection 2016.
6
Statistical analysis of tablet breakability methods.片剂易碎性方法的统计分析
J Pharm Pharm Sci. 2002 May-Aug;5(2):190-8.
7
The practice and clinical implications of tablet splitting in international health.国际卫生领域中片剂分劈的实践和临床意义。
Trop Med Int Health. 2014 Jul;19(7):754-60. doi: 10.1111/tmi.12309. Epub 2014 Apr 7.
8
Tablet-breaking ability of older persons with type 2 diabetes mellitus.2型糖尿病老年人的片剂掰碎能力。
Diabetes Educ. 2001 Jul-Aug;27(4):530-40. doi: 10.1177/014572170102700408.
9
The accuracy, precision and sustainability of different techniques for tablet subdivision: breaking by hand and the use of tablet splitters or a kitchen knife.不同片剂分割技术的准确性、精密度和可持续性:手工掰开和使用片剂分割器或厨房刀。
Int J Pharm. 2014 May 15;466(1-2):44-51. doi: 10.1016/j.ijpharm.2014.02.031. Epub 2014 Feb 21.
10
[Tablet splitting: do discount contracts influence prescribing quality?].[药片分割:折扣合同会影响处方质量吗?]
Med Klin (Munich). 2008 Aug 15;103(8):569-74. doi: 10.1007/s00063-008-1092-1. Epub 2008 Sep 21.

引用本文的文献

1
Concerns regarding tablet splitting: a systematic review.关于片剂分割的担忧:一项系统评价
BJGP Open. 2022 Sep 28;6(3). doi: 10.3399/BJGPO.2022.0001. Print 2022 Sep.
2
Tablet Splitting of Antiepileptic Drugs in Pediatric Epilepsy: Potential Effect on Plasma Drug Concentrations.小儿癫痫中抗癫痫药物的片剂分割:对血浆药物浓度的潜在影响。
Paediatr Drugs. 2016 Dec;18(6):451-463. doi: 10.1007/s40272-016-0193-1.
3
The use of oral suspension and rationally prescribing alternatives may be supplemental to the implementation of clopidogrel new algorithm comprising CYP2C19 pharmacogenetics and drug interactions.
使用口服混悬剂并合理开具替代药物可能是对包含CYP2C19药物遗传学和药物相互作用的氯吡格雷新算法实施的补充。
Ther Clin Risk Manag. 2016 Mar 2;12:351-2. doi: 10.2147/TCRM.S103196. eCollection 2016.